Trial
ERASURE
Phase 3 psoriasis trial of secukinumab.
Also called: ERASURE trial, Efficacy of Response and Safety of Two Fixed Secukinumab Regimens
Sparsely connected — only 1 link recorded so far.
In short
- 1What it is: a trial in therapies and applications.
- 2How it connects: acts on 1 and is affected by 0 concepts — mostly 1 therapy.
- 3Where it sits: trial on the 15-step immune chain.
What it does
N=738; secukinumab vs placebo in moderate-severe plaque psoriasis; PASI 90 at week 12: 150mg 59.2%, 300mg 77.1% vs placebo 4.9%; established IL-17A blockade efficacy in psoriasis; foundational for anti-IL-17A approval
Its connections at a glance
Each dot is a concept directly linked to ERASURE. Colours show the kind of concept.
Learn next
Sources & evidenceloading…
Loading reviewed sources…
Graph ID TR004 · concept status: established. Select any connection above to inspect evidence for that specific link.